Copied
 
 
Formål
Formål
Selskabets formål er i ind- og udland at drive fabrikation og handel dels direkte, dels ved anbringelse af kapital i andre foretagender. Selskabet kan i øvrigt foretage investeringer i fast ejendom, drive finansieringsvirksomhed samt udøve enhver efter bestyrelsens skøn i forbindelse med formålet stående virksomhed.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 12.03.2014 (3706 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 09.08.1961 (22914 dage).
Ingen historik.
Branche
Branche
Fremstilling af farmaceutiske præparater (212000).
Sidst opdateret den 25.12.2007 og angivet som gældende fra 01.01.2008 (5968 dage).
HistorikStartStop
Fremstilling af farmaceutiske præparater (212000)01.01.2008
Medicinalvarefabrikker (244200)09.08.196131.12.2007
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 09.08.1961 (22914 dage).
Ingen historik.
Revisor
Revisor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 17.03.2020 og angivet som gældende fra 11.03.2020 (1515 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 22.11.2013 og angivet som gældende fra 09.08.1961 (22914 dage).
Ingen historik.
Kontakt
HistorikStartStop
mailbox@alk-abello.com23.01.200212.01.2003
Virksomheden har ikke ændret Kontakt i sin levetid.
Ingen nuværende registrering.
Telefon
Telefonnummer
45747576.
Sidst opdateret den 15.06.2012 og angivet som gældende fra 01.02.2007 (6302 dage).
HistorikStartStop
4574757601.02.2007
4574744523.01.200012.01.2003
Navne
Binavne
Binavne
ALK A/S.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 09.08.1961 (22914 dage).
HistorikStartStop
ALK A/S09.08.1961
ALLERGOLOGISK LABORATORIUM A/S09.08.1961
DIAGNOSELABORATORIET AF 1977 A/S09.08.1961
ALK-ABELLO A/S09.08.196130.01.1998
DIAGNOSELABORATORIET AF 1977 A/S09.08.196130.01.1998
Tegningsregel
Tegningsregel
Selskabet tegnes af bestyrelsens formand eller næstformand i forening med et bestyrelsesmedlem, bestyrelsens formand eller næstformand i forening med en direktør, eller den administrerende direktør i forening med en anden direktør.
Sidst opdateret den 24.03.2017 og angivet som gældende fra 24.03.2017 (2598 dage).
Fortolkning (5 tegningsmuligheder)
formanden + 1 bestyrelsesmedlem
næstformanden + 1 bestyrelsesmedlem
formanden + 1 direktør
næstformanden + 1 direktør
direktøren + 1 anden_direktør
HistorikStartStop
Selskabet tegnes af bestyrelsens formand eller næstformand i forening med et bestyrelsesmedlem, bestyrelsens formand eller næstformand i forening med en direktør, eller den administrerende direktør i forening med en anden direktør24.03.2017
Selskabet tegnes af (i) bestyrelsens formand eller næstformand i forening med et bestyrelsesmedlem, (ii) bestyrelsens formand eller næstformand i forening med en direktør, eller (iii) den administrerende direktør i forening med en anden direktør12.03.201423.03.2017
Ansatte
04.05.2024
Kapital
04.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse D
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibili- ties under those standards and require- ments are further described in the Audi- tor’s responsibilities for the audit of the Financial Statements section of our report. We believe that the audit evidence we have obtained is sufficient and appro- priate to provide a basis for our opinion. Independence We are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ Inter- national Code of Ethics for Professional Accountants (IESBA Code) and the addi- tional ethical requirements applicable in Denmark. We have also fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. To the best of our knowledge and belief, prohibited non-audit services referred to in Article 5(1) of Regulation (EU) No 537/2014 were not provided. Appointment We were first appointed auditors of ALK-Abello A/S on 11 March 2020 for the financial year 2020. We have been reap- pointed annually by shareholder reso- lution for a total period of uninterrupted engagement of 4 years including the financial year 2023.
Konklusion (revision):Our opinion In our opinion, the Consolidated Financial Statements give a true and fair view of the Group’s financial position at 31 December 2023 and of the results of the Group’s operations and cash flows for the financial year 1 January to 31 December 2023 in accordance with IFRS Accounting Stand- ards as adopted by the EU and further requirements in the Danish Financial Statements Act. Moreover, in our opinion, the Parent Company Financial Statements give a true and fair view of the Parent Company’s financial position at 31 December 2023 and of the results of the Parent Company’s operations for the financial year 1 January to 31 December 2023 in accordance with the Danish Financial Statements Act. Our opinion is consistent with our Auditor’s Long-form Report to the Audit Committee and the Board of Directors. What we have audited The Consolidated Financial Statements (pp 60-101) and the Parent Company Financial Statements (pp 102-114) of ALK-Abello A/S for the financial year 1 January to 31 December 2023 comprise income statement, balance sheet, state- ment of changes in equity and notes, including material accounting policy information for the Group as well as for the Parent Company, and statement of comprehensive income and cash flow statement for the Group. Collectively referred to as the “Financial Statements”.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Manage- ment’s Review (pp 1-53 and 115). Our opinion on the Financial Statements døs not cover Management’s Review, and we do not express any form of assur- ance conclusion thereon. In connection with our audit of the Finan- cial Statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the Financial Statements or our know- ledge obtained in the audit, or otherwise appears to be materially misstated. Moreover, we considered whether Management’s Review includes the disclosures required by the Danish Financial Statements Act and Article 8 of Regulation (EU) 2020/852 (EU Taxonomy Regulation). Based on the work we have performed, in our view, Management’s Review is in accordance with the Consolidated Finan- cial Statements and the Parent Company Financial Statements and has been prepared in accordance with the require- ments of the Danish Financial Statements Act and the disclosure requirements of Article 8 of Regulation (EU) 2020/852 (EU Taxonomy Regulation). We did not identify any material misstatement in Manage- ment’s Review.
Bibranche
Bibranche
Fremstilling af andre kemiske produkter i.a.n.
Sidst opdateret den 01.02.2008 og angivet som gældende fra 01.01.2008 (5968 dage).
HistorikStartStop
Fremstilling af andre kemiske produkter i.a.n01.01.2008
Fremstilling af andre kemiske produkter i øvrigt09.08.196131.12.2007
Børsnoteret
04.05.2024
Børsnoteret
true.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 23.12.2005 (6707 dage).
Ingen historik.
Hjemmeside
04.05.2024
Ingen nuværende registrering.
Ingen historik.